Tarceva and Lung Cancer
Tarceva® (erlotinib) is a cancer medication that comes in the form of a tablet. It is taken daily and is approved to treat non-small cell lung cancer in adults.
There are two main types of lung cancer: small cell lung cancer and non-small cell lung cancer. Non-small cell lung cancer is the more common type. It generally spreads more slowly than small cell lung cancer. Tarceva is specifically approved for non-small cell lung cancer that has advanced or spread to other areas of the body (has metastasized).
When used for non-small cell lung cancer, Tarceva is not intended to be taken with other chemotherapy medications.
(Click Tarceva Uses for more details on this topic, including information on other approved uses, how it works, and possible "off-label" uses.)